These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 373006

  • 1. Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen [proceedings].
    Schooler NR, Levine J, Severe JB.
    Psychopharmacol Bull; 1979 Apr; 15(2):44-7. PubMed ID: 373006
    [No Abstract] [Full Text] [Related]

  • 2. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
    Levine J, Schooler NR, Severe J, Escobar J, Gelenberg A, Mandel M, Sovner R, Steinbook R.
    Adv Biochem Psychopharmacol; 1980 Apr; 24():483-93. PubMed ID: 6996445
    [No Abstract] [Full Text] [Related]

  • 3. [Experience with depot neuroleptics].
    Arató M, Erdós A.
    Orv Hetil; 1979 Apr 29; 120(17):1015-21. PubMed ID: 372888
    [No Abstract] [Full Text] [Related]

  • 4. Dosage and side effect comparisons betweel oral and depot fluphenazine.
    Schooler NR, Levine J.
    Psychopharmacol Bull; 1977 Jul 29; 13(3):29-31. PubMed ID: 329328
    [No Abstract] [Full Text] [Related]

  • 5. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F.
    Act Nerv Super (Praha); 1974 Aug 29; 16(3):167-8. PubMed ID: 4607824
    [No Abstract] [Full Text] [Related]

  • 6. Long-acting phenothiazines for treatment of schizophrenia.
    Med Lett Drugs Ther; 1976 Jan 16; 18(2):6-7. PubMed ID: 1107791
    [No Abstract] [Full Text] [Related]

  • 7. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
    Wiles DH, Gelder MG.
    Adv Biochem Psychopharmacol; 1980 Jan 16; 24():599-602. PubMed ID: 7405678
    [No Abstract] [Full Text] [Related]

  • 8. [Results of therapy with Lyogen-Depot in schizophrenic diseases].
    Friemert K, Beier R, Vehreschild T.
    Psychiatr Neurol Med Psychol (Leipz); 1974 Jun 16; 26(6):374-7. PubMed ID: 4849639
    [No Abstract] [Full Text] [Related]

  • 9. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
    Tsutsul'kovskaia MIa, Minsker EI, Panteleeva GP, Mazurskii MB, Pekunova LG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 Jun 16; 73(5):753-8. PubMed ID: 4718619
    [No Abstract] [Full Text] [Related]

  • 10. The use of depot neuroleptics: clinical experience in the United States.
    Kane JM.
    J Clin Psychiatry; 1984 May 16; 45(5 Pt 2):5-12. PubMed ID: 6370987
    [Abstract] [Full Text] [Related]

  • 11. [Prevention of relapse in the era of depot neuroleptics and social psychiatry].
    Schindler R.
    Nervenarzt; 1976 May 16; 47(5):347-50. PubMed ID: 179025
    [No Abstract] [Full Text] [Related]

  • 12. A pilot study of "low-dose" fluphenazine decanoate in outpatient schizophrenics [proceedings].
    Kane J, Rifkin A, Quitkin F.
    Psychopharmacol Bull; 1979 Apr 16; 15(2):78-80. PubMed ID: 373007
    [No Abstract] [Full Text] [Related]

  • 13. Our experience with Moditene-Depot in chronic schizophrenia.
    Gamkrelidze ShA, Putkoradze-Gamkrelidze NA.
    Act Nerv Super (Praha); 1973 Aug 16; 15(3):169. PubMed ID: 4769133
    [No Abstract] [Full Text] [Related]

  • 14. [Personal experience with prolonged-action fluphenazine].
    Król K, Krystof J.
    Psychiatr Pol; 1974 Aug 16; 8(2):149-55. PubMed ID: 4830322
    [No Abstract] [Full Text] [Related]

  • 15. The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine.
    Schooler NR, Levine J.
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul 16; 9(4):159-69. PubMed ID: 790413
    [Abstract] [Full Text] [Related]

  • 16. [Depot fluphenazine as a means of stabilizing remission in cases of schizophrenia].
    Vovin RIa, Vovina EN.
    Psychiatr Neurol Med Psychol Beih; 1975 Jul 16; 20-21():183-7. PubMed ID: 829620
    [Abstract] [Full Text] [Related]

  • 17. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
    Cohen BM, Waternaux C, Chouinard G, Sommer BR, Jones B.
    J Clin Psychopharmacol; 1985 Dec 16; 5(6):328-32. PubMed ID: 4066997
    [Abstract] [Full Text] [Related]

  • 18. [Effect of moditen-depot therapy on the duration and quality of remissions in schizophrenia patients].
    Vovin RIa, Gurovich IIa, Eryshev OF, Zaĭtsev SG, Magalif AIu.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977 Dec 16; 77(5):743-9. PubMed ID: 899478
    [Abstract] [Full Text] [Related]

  • 19. [Long-term therapy with depot-fluphenazine Dapotum in schizophrenia].
    Moldenhauer B.
    Med Welt; 1966 Jul 02; 27():1477-81. PubMed ID: 5985539
    [No Abstract] [Full Text] [Related]

  • 20. Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings].
    Rifkin A, Quitkin F, Kane J, Klein DF.
    Psychopharmacol Bull; 1977 Apr 02; 13(2):49-50. PubMed ID: 323910
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.